Literature DB >> 8906226

Contribution of T lymphocytes to the development of bleomycin-induced pulmonary fibrosis.

J Zhu1, D A Cohen, S N Goud, A M Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8906226     DOI： 10.1111/j.1749-6632.1996.tb32581.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma.

Authors:  Ji Hyung Kim; Hye Young Kim; Sanghee Kim; Jin-Haeng Chung; Weon Seo Park; Doo Hyun Chung
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

2.  Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury.

Authors:  Michael J Segel; Rami Aqeilan; Keren Zilka; Haya Lorberboum-Galski; Shulamit B Wallach-Dayan; Michael W Conner; Thomas G Christensen; Raphael Breuer
Journal:  Int J Exp Pathol       Date:  2005-10       Impact factor: 1.925

3.  Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes.

Authors:  Elizabeth I Majeski; Manjeet K Paintlia; Andrea D Lopez; Russell A Harley; Steven D London; Lucille London
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

4.  IL-17 producing gammadelta T cells are required for a controlled inflammatory response after bleomycin-induced lung injury.

Authors:  Ruedi K Braun; Christina Ferrick; Paul Neubauer; Michael Sjoding; Anja Sterner-Kock; Martin Kock; Lei Putney; David A Ferrick; Dallas M Hyde; Robert B Love
Journal:  Inflammation       Date:  2008-03-13       Impact factor: 4.092

5.  Soluble TNF mediates the transition from pulmonary inflammation to fibrosis.

Authors:  Nikos Oikonomou; Vaggelis Harokopos; Jonathan Zalevsky; Christos Valavanis; Anastasia Kotanidou; David E Szymkowski; George Kollias; Vassilis Aidinis
Journal:  PLoS One       Date:  2006-12-27       Impact factor: 3.240

6.  Fine mapping of the major bleomycin-induced pulmonary fibrosis susceptibility locus in mice.

Authors:  Marie-Eve Bergeron; Anguel Stefanov; Christina K Haston
Journal:  Mamm Genome       Date:  2018-09-01       Impact factor: 2.957

7.  Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis.

Authors:  A Hünerwadel; S Fagagnini; G Rogler; C Lutz; S U Jaeger; C Mamie; B Weder; P A Ruiz; M Hausmann
Journal:  Sci Rep       Date:  2018-10-12       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.